Skip to content
healthcare.dev

ZIEXTENZO

NDC 61314-866, pegfilgrastim-bmez, injection, from Sandoz Inc.

Product NDC
61314-866
Status
Listed
Labeler
Sandoz Inc
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761045
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61314-866 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PEGFILGRASTIM6 mg/.6mL

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
61314-866-02613140866021 BLISTER PACK in 1 CARTON (61314-866-02) / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7dada041-6528-4acf-809c-62d271538c9a
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=61314-866

Use it

Look up 61314-866 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61314-866 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61314-866. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.